No association between HLA-B and cutaneous reactions to sulphonamides in human immunodeficiency virus-infected patients.
Vitezica
Z G
ZG
Wolkenstein
P
P
Lonjou
C
C
Eliaszewicz
M
M
Sicard
X
X
Roujeau
J-C
JC
Hovnanian
A
A
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D015235:HLA-B Antigens / Q000235:genetics*; D006801:Humans; D008297:Male; D011446:Prospective Studies; D013449:Sulfonamides / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D015235:HLA-B Antigens; D013449:Sulfonamides